Target intelligence / Profile preview

Immune System Cells & Cytokines

Molecular classification
Other, Biological System
01

Overview

Immune System Cells & Cytokines refers to the collective cellular and molecular network responsible for host defense and maintaining biological homeostasis. This category encompasses a diverse array of leukocytes, including T cells, B cells, macrophages, and neutrophils, as well as the signaling proteins known as cytokines (e.g., interleukins, interferons, and tumor necrosis factors) that coordinate their actions (StatPearls: Physiology, Immune Response, 2023). While these components are vital for protecting against pathogens and surveilling for malignant cells, their dysregulation is a central driver of chronic inflammatory conditions and autoimmune diseases (NIH: Cytokines and the Immune Response, 2022). In the context of drug development, specific molecules within this system—such as the IL-6 receptor or TNF-alpha—serve as high-value therapeutic targets for biologics and small molecules (PubMed: Therapeutic targeting of cytokines, 2021). However, the term itself is considered a broad biological category rather than a discrete molecular target, as it aggregates thousands of distinct proteins and cell types with varying functions. Consequently, therapeutic interventions typically focus on modulating specific pathways within this system to achieve immunosuppression or immunostimulation depending on the disease context (Nature Reviews Drug Discovery: Evolution of Immune Checkpoint Blockade, 2020).

Other names
Immune system componentsLeukocytes and inflammatory mediatorsImmune effectorsCytokines and immune cells
02

Mechanism of action

Modulation of immune activity through cytokine neutralization, receptor blockade, or depletion of specific immune cell subsets.

03

Biological functions

Immune responseInflammationCell signalingHost defenseCell proliferationApoptosis
04

Disease associations

InflammationCancerInfectionAutoimmune diseaseAllergy
05

Safety considerations

Systemic immunosuppressionIncreased risk of opportunistic infectionsCytokine release syndrome (CRS)Infusion reactionsAutoimmunity (immune-related adverse events)
06

Interacting drugs

Infliximab

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6) levelsTumor necrosis factor (TNF) levelsAbsolute lymphocyte countCytokine profile

Beyond the preview

Go deeper on Immune System Cells & Cytokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune System Cells & Cytokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call